- Home
- NTHI vs CANG Comparison
NTHI vs CANG Comparison
Compare NTHI & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | CANG |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | 5 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.6M | 116.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NTHI | CANG |
|---|---|---|
| Price | $3.44 | $1.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | $3.00 |
| AVG Volume (30 Days) | 65.4K | ★ 588.3K |
| Earning Date | 05-19-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $428.72 |
| Revenue Next Year | N/A | $18.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.01 | $0.17 |
| 52 Week High | $12.99 | $5.55 |
Technical Indicators
Market Signals| Indicator | NTHI | CANG |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 81.69 |
| Support Level | $3.01 | $1.18 |
| Resistance Level | $4.59 | N/A |
| Average True Range (ATR) | 0.38 | 0.09 |
| MACD | -0.03 | 0.19 |
| Stochastic Oscillator | 25.55 | 83.18 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About CANG Cango Inc. each representing two (2)
Cango Inc is a Bitcoin mining company with a vision to establish an integrated, world-wide infrastructure platform capable of powering the future digital economy. The operations are divided into two reportable segments (i) Bitcoin Mining Business and (ii) International Automobile Trading Business. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa. Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through its subsidiary.